CBIC / GST notification · 01 Feb 2025
[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II, SECTION 3, SUB-SECTION (i)] GOVERNMENT OF INDIA MINISTRY OF FINANCE (Department of Revenue) Notification No. 09/2025-Customs New Delhi, the 1st February, 2025 G.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Custom…
Official record
Open source page[TO BE PUBLISHED IN THE GAZETTE OF INDIA, EXTRAORDINARY, PART II, SECTION 3, SUB-SECTION (i)]
GOVERNMENT OF INDIA
MINISTRY OF FINANCE
(Department of Revenue)
Notification No. 09/2025-Customs
New Delhi, the 1^st February, 2025
G.S.R….(E).- In exercise of the powers conferred by sub-section (1) of section 25 of the Customs Act, 1962 (52 of 1962), the Central Government, on being satisfied that it is necessary in the public interest so to do, hereby makes the following further amendments in the notification of the Government of India in the Ministry of Finance (Department of Revenue) No. 16/2017-Customs, dated the 20^th April, 2017, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 394(E), dated the 20^th April, 2017, namely :-
In the said notification, in the TABLE, after serial number 52 and the entries relating thereto, the following serial numbers and the entries shall be inserted, namely :-
| (1) | (2) | (3) | (4) |
|---|---|---|---|
| “53. | Pembrolizumab | Key- PAP 1.0 | MSD Pharmaceuticals |
| 54. | Pembrolizumab | KIRAN | MSD Pharmaceuticals |
| 55. | Lorlatinib | LorbriquaCare | Pfizer Products India Private Ltd. |
| 56. | Dacomitinib | DacoCare | Pfizer Products India Private Ltd. |
| 57. | Inotuzumab Ozogamicin | HemaCare | Pfizer Products India Private Ltd. |
| 58. | Ribociclib | UMAANG | Novartis Healthcare Pvt. Ltd. |
| 59. | Dabrafenib | UMAANG | Novartis Healthcare Pvt. Ltd. |
| 60. | Selumetinib | AstraZeneca Pharma PAP | AstraZeneca Pharma India Limited |
| 61. | Benralizumab | AstraZeneca Pharma PAP | AstraZeneca Pharma India Limited |
| 62. | Fulvestrant | AstraZeneca Pharma PAP | AstraZeneca Pharma India Limited |
| 63. | Acalabrutinib | AstraZeneca Pharma PAP | AstraZeneca Pharma India Limited |
| 64. | Olaparib | AstraZeneca Pharma PAP | AstraZeneca Pharma India Limited |
| 65. | Amivantamab | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 66. | Teclistamab | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 67. | Ustekinumab | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 68. | Daratumumab | ||
| And hyaluronidase-fihj | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. | |
| 69. | Ibrutinib | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 70. | Bortezomib | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 71. | Daratumumab | Johnson and Johnson PAP | Johnson & Johnson Pvt. Ltd. |
| 72. | Cetuximab | Rainbow PAP | Merck Specialties Pvt. Ltd. |
| 73. | Avelumab | My Bavencio Assist Program | Merck Specialties Pvt. Ltd. |
| 74. | Tepotinib | My Tepmetko Patient Access Program | Merck Specialties Pvt. Ltd. |
| 75. | Brentuximab Vedotin | Takeda PAP | Takeda Biopharmaceuticals India Pvt. Limited |
| 76. | Vedolizumab | Takeda PAP | Takeda Biopharmaceuticals India Pvt. Limited |
| 77. | Velaglucerase Alpha | Takeda PAP | Takeda Biopharmaceuticals India Pvt. Limited |
| 78. | Agalsidase Alpha | Takeda PAP | Takeda Biopharmaceuticals India Pvt. Limited |
| 79. | Idursulphase | Takeda PAP | Takeda Biopharmaceuticals India Pvt. Limited |
| 80. | Mepolizumab | GSK Pharmaceuticals Limited | GSK Pharmaceuticals Limited |
| 81. | Alectinib | The Blue Tree | Roche Products India Private Ltd. |
| 82. | Risdiplam Powder | The Blue Tree | Roche Products India Private Ltd. |
| 83. | Emicizumab | The Blue Tree | Roche Products India Private Ltd. |
| 84. | Atezolizumab | The Blue Tree | Roche Products India Private Ltd. |
| 85. | Pertuzumab + trastuzumab | The Blue Tree | Roche Products India Private Ltd. |
| 86. | Ocrelizumab | The Blue Tree | Roche Products India Private Ltd. |
| 87. | Polatuzumab vedotin | The Blue Tree | Roche Products India Private Ltd. |
| 88. | Faricimab | The Blue Tree | Roche Products India Private Ltd. |
| 89. | Luspatercept | Bristol-Myers Patient Assistance Program | Bristol-Myers Squibb India Pvt. Ltd. ”. |
[F. No. 334/03/2025-TRU]
(Amreeta Titus)
Deputy Secretary to the Government of India
Note: The principal notification No. 16/2017-Customs, dated the 20^th April, 2017 was published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-Section (i), vide number G.S.R. 394(E), dated the 30^th June, 2017 and last amended vide notification No. 38/2024-Customs, dated the 23^rd July, 2024, published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), vide number G.S.R. 441(E), dated the 23^rd July, 2024.